Pre-order Enquiry
Request Free Sample
Global Natural Killer (NK) Cell Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
SKU ID : GIR-17723954 | Publishing Date : 21-Mar-2021 | No. of pages : 93
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Natural Killer (NK) Cell Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
1 Market Overview1.1 Product Overview and Scope of Natural Killer (NK) Cell Therapeutics
1.2 Classification of Natural Killer (NK) Cell Therapeutics by Type
1.2.1 Overview: Global Natural Killer (NK) Cell Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2020
1.2.3 Mogamulizumab
1.2.4 Lorvotuzumab Mertansine
1.2.5 Others
1.3 Global Natural Killer (NK) Cell Therapeutics Market by Application
1.3.1 Overview: Global Natural Killer (NK) Cell Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Global Natural Killer (NK) Cell Therapeutics Market Size & Forecast
1.5 Global Natural Killer (NK) Cell Therapeutics Market Size and Forecast by Region
1.5.1 Global Natural Killer (NK) Cell Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Natural Killer (NK) Cell Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Natural Killer (NK) Cell Therapeutics Market Drivers
1.6.2 Natural Killer (NK) Cell Therapeutics Market Restraints
1.6.3 Natural Killer (NK) Cell Therapeutics Trends Analysis
2 Company Profiles
2.1 Chipscreen Biosciences
2.1.1 Chipscreen Biosciences Details
2.1.2 Chipscreen Biosciences Major Business
2.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product and Solutions
2.1.4 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Chipscreen Biosciences Recent Developments and Future Plans
2.2 Affimed NV
2.2.1 Affimed NV Details
2.2.2 Affimed NV Major Business
2.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Product and Solutions
2.2.4 Affimed NV Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Affimed NV Recent Developments and Future Plans
2.3 Altor BioScience
2.3.1 Altor BioScience Details
2.3.2 Altor BioScience Major Business
2.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Product and Solutions
2.3.4 Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Altor BioScience Recent Developments and Future Plans
2.4 Innate Pharma
2.4.1 Innate Pharma Details
2.4.2 Innate Pharma Major Business
2.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Product and Solutions
2.4.4 Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Innate Pharma Recent Developments and Future Plans
2.5 Takeda
2.5.1 Takeda Details
2.5.2 Takeda Major Business
2.5.3 Takeda Natural Killer (NK) Cell Therapeutics Product and Solutions
2.5.4 Takeda Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Takeda Recent Developments and Future Plans
2.6 Sorrento Therapeutics
2.6.1 Sorrento Therapeutics Details
2.6.2 Sorrento Therapeutics Major Business
2.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product and Solutions
2.6.4 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sorrento Therapeutics Recent Developments and Future Plans
2.7 NantKwest
2.7.1 NantKwest Details
2.7.2 NantKwest Major Business
2.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Product and Solutions
2.7.4 NantKwest Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 NantKwest Recent Developments and Future Plans
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product and Solutions
2.8.4 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.9 NKT
2.9.1 NKT Details
2.9.2 NKT Major Business
2.9.3 NKT Natural Killer (NK) Cell Therapeutics Product and Solutions
2.9.4 NKT Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 NKT Recent Developments and Future Plans
2.10 Henry Ford Health Services
2.10.1 Henry Ford Health Services Details
2.10.2 Henry Ford Health Services Major Business
2.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product and Solutions
2.10.4 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Henry Ford Health Services Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Natural Killer (NK) Cell Therapeutics Players Market Share
3.2.2 Top 10 Natural Killer (NK) Cell Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Natural Killer (NK) Cell Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Natural Killer (NK) Cell Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Natural Killer (NK) Cell Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Natural Killer (NK) Cell Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
6.2 North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Country
6.3.1 North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
7.2 Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country
7.3.1 Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region
8.3.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2016-2026)
8.3.2 China Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
9.2 South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
9.3 South America Natural Killer (NK) Cell Therapeutics Market Size by Country
9.3.1 South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country
10.3.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Natural Killer (NK) Cell Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Figures, Tables and Charts Available in Global Natural Killer (NK) Cell Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
List of TablesTable 1. Global Natural Killer (NK) Cell Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Natural Killer (NK) Cell Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Natural Killer (NK) Cell Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Chipscreen Biosciences Corporate Information, Head Office, and Major Competitors
Table 7. Chipscreen Biosciences Major Business
Table 8. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 9. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Affimed NV Corporate Information, Head Office, and Major Competitors
Table 11. Affimed NV Major Business
Table 12. Affimed NV Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 13. Affimed NV Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Altor BioScience Corporate Information, Head Office, and Major Competitors
Table 15. Altor BioScience Major Business
Table 16. Altor BioScience Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 17. Altor BioScience Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Innate Pharma Corporate Information, Head Office, and Major Competitors
Table 19. Innate Pharma Major Business
Table 20. Innate Pharma Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 21. Innate Pharma Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Takeda Corporate Information, Head Office, and Major Competitors
Table 23. Takeda Major Business
Table 24. Takeda Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 25. Takeda Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Sorrento Therapeutics Major Business
Table 28. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 29. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. NantKwest Corporate Information, Head Office, and Major Competitors
Table 31. NantKwest Major Business
Table 32. NantKwest Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 33. NantKwest Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 35. Bristol-Myers Squibb Major Business
Table 36. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 37. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. NKT Corporate Information, Head Office, and Major Competitors
Table 39. NKT Major Business
Table 40. NKT Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 41. NKT Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Henry Ford Health Services Corporate Information, Head Office, and Major Competitors
Table 43. Henry Ford Health Services Major Business
Table 44. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product and Solutions
Table 45. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Natural Killer (NK) Cell Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Natural Killer (NK) Cell Therapeutics Players Head Office, Products and Services Provided
Table 50. Natural Killer (NK) Cell Therapeutics Mergers & Acquisitions in the Past Five Years
Table 51. Natural Killer (NK) Cell Therapeutics New Entrants and Expansion Plans
Table 52. Global Natural Killer (NK) Cell Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type (2016-2021)
Table 54. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Type (2021-2026)
Table 55. Global Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021)
Table 56. Global Natural Killer (NK) Cell Therapeutics Revenue Forecast by Application (2021-2026)
Table 57. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Natural Killer (NK) Cell Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Natural Killer (NK) Cell Therapeutics Picture
Figure 2. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type in 2020
Figure 3. Mogamulizumab
Figure 4. Lorvotuzumab Mertansine
Figure 5. Others
Figure 6. Natural Killer (NK) Cell Therapeutics Revenue Market Share by Application in 2020
Figure 7. Cancer Picture
Figure 8. Cardiovascular Diseases Picture
Figure 9. Others Picture
Figure 10. Global Natural Killer (NK) Cell Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Natural Killer (NK) Cell Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2016-2026)
Figure 13. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region in 2020
Figure 14. North America Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Natural Killer (NK) Cell Therapeutics Market Drivers
Figure 20. Natural Killer (NK) Cell Therapeutics Market Restraints
Figure 21. Natural Killer (NK) Cell Therapeutics Market Trends
Figure 22. Chipscreen Biosciences Recent Developments and Future Plans
Figure 23. Affimed NV Recent Developments and Future Plans
Figure 24. Altor BioScience Recent Developments and Future Plans
Figure 25. Innate Pharma Recent Developments and Future Plans
Figure 26. Takeda Recent Developments and Future Plans
Figure 27. Sorrento Therapeutics Recent Developments and Future Plans
Figure 28. NantKwest Recent Developments and Future Plans
Figure 29. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 30. NKT Recent Developments and Future Plans
Figure 31. Henry Ford Health Services Recent Developments and Future Plans
Figure 32. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players in 2020
Figure 33. Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 34. Global Top 3 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2020
Figure 35. Global Top 10 Players Natural Killer (NK) Cell Therapeutics Revenue Market Share in 2020
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 37. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Type in 2020
Figure 38. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Type (2021-2026)
Figure 39. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application in 2020
Figure 40. Global Natural Killer (NK) Cell Therapeutics Market Share Forecast by Application (2021-2026)
Figure 41. North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 42. North America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 43. North America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 44. United States Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 48. Europe Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 49. Europe Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 50. Germany Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 56. Asia-Pacific Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Natural Killer (NK) Cell Therapeutics Revenue Market Share by Region (2016-2026)
Figure 58. China Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South Korea Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 65. South America Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 66. South America Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Type (2016-2026)
Figure 70. Middle East and Africa Natural Killer (NK) Cell Therapeutics Sales Market Share by Application (2016-2026)
Figure 71. Middle East and Africa Natural Killer (NK) Cell Therapeutics Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. UAE Natural Killer (NK) Cell Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source
Keyplayers in Global Natural Killer (NK) Cell Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Chipscreen BiosciencesAffimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
